查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1715415

介入性肿瘤学市场：按产品类型、癌症类型、技术和最终用户 - 2025-2030 年全球预测

Interventional Oncology Market by Product, Cancer Type, Technology, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计介入肿瘤学市场在 2024 年的价值将达到 25.5 亿美元，到 2025 年将以 7.39% 的复合年增长率增长至 27.3 亿美元，到 2030 年将达到 39.2 亿美元。

介入性肿瘤学的全面介绍

主要市场统计数据
基准年2024年 25.5亿美元
预计2025年 27.3亿美元
预测年份 2030 39.2亿美元
复合年增长率（%） 7.39%

介入性肿瘤学是一个充满活力且快速发展的领域，它将尖端技术创新与对癌症生物学的深刻理解相结合。在当今复杂的医疗保健环境中，这一专业正在成为恶性肿瘤管理和治疗的关键组成部分。微创技术的引入不仅重新定义了治疗模式，也为患者提供了比传统手术更安全、更有效的替代方案。作为肿瘤学的新兴分支，介入肿瘤学利用先进的影像技术、客製化的设备和多重模式方法，透过提高精确度和准确度来改善患者的治疗效果。

该报告全面介绍了该行业的现状和未来潜力。它分析了关键的技术趋势、市场驱动因素和设备开发创新。我们也讨论了它在各种癌症类型中的临床应用以及由此产生的治疗策略的转变。本摘要着重于可行的见解，既是策略指南，也是知识宝库，为从业人员、决策者和产业领导者提供宝贵的观点。

本报告强调了在快速变化的医疗保健领域中适应性的重要性，并为深入检验影响这一肿瘤学专业领域的市场细分、区域发展和竞争动态奠定了基础。在这个过程中，我们强调了研究和合作在推动介入肿瘤学下一波突破方面将发挥的重要作用。

介入性肿瘤学领域的变革

近年来，介入肿瘤学领域发生了再形成变化。技术进步带来了新的工具和方法，重新定义了癌症的临床管理。这种演变很大程度上是由精确度的提高、安全性的改善以及对更个人化的治疗通讯协定的需求所推动的。

创新的影像技术，加上小型化、高度专业化的设备的发展，使临床医生能够以惊人的精度导航复杂的肿瘤解剖结构。这些发展显着减少了治疗时间和住院时间，同时也最大限度地减少了与更具侵入性的手术相关的副作用。人工智慧和预测分析的整合将进一步支持临床决策，确保治疗不仅及时，还能根据每位患者的具体情况进行客製化。

此外，工程学、放射学和肿瘤学等多学科专业知识的融合构成了这项变革的支柱。这种整体整合增强了整个治疗过程并简化了患者照护。随着市场格局的不断发展，新的治疗方法和程序创新不断涌现，挑战传统模式。这些变化所带来的动力凸显了相关人员不断适应的必要性，为该产业的强劲成长和创新铺平了道路。

关键细分洞察与市场动态

了解介入性肿瘤学市场动态的关键是全面分析关键细分参数。对产品尺寸的研究揭示了包括消融、栓塞和支持设备在内的频谱。每个类别中都有专门的组件，例如用于冷冻设备和高强度聚焦超音波、用于栓塞设备的药物释放型珠和微球以及用于支援设备的导管导引线和引入套件。这种详细的分类将使相关人员能够识别利基机会并满足不同临床干预的特定需求。

根据癌症类型进行细分，将市场划分为大肠直肠癌、肾癌、肝癌和肺癌，进一步细化了这项分析。这些分类突显了不同的临床应用和不同癌症的发生率，进而影响技术采用和研究优先顺序。

此外，涵盖近距离放射治疗、影像导航放射治疗、微波消融和射频消融术的技术领域描绘出一个正在快速整合创新治疗方式的领域。这种分层方法提供了程序复杂性和新竞争优势的详细视图。

最后，按最终用户细分的重点是主要临床环境，例如门诊手术中心、癌症研究机构和医院。分析这些部分可以为了解基础设施需求以及技术在加强患者管理方面不断变化的作用提供可行的见解。综合起来，这些细分提供了对市场的细緻了解，突显了成长趋势和策略投资领域。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 全球癌症发生率正在上升
      • 提高患者和医疗保健提供者对介入性肿瘤学作为治疗选择的认识和接受度
      • 全球医疗保健支出和投资不断增长
    • 限制因素
      • 介入性肿瘤治疗费用高成本
    • 机会
      • 整合人工智慧优化介入肿瘤学的工作流程与诊断
      • 冷冻消融技术在癌症微创治疗的进展
    • 任务
      • 介入性肿瘤学解决新出现的临床疗效和安全性问题
  • 市场区隔分析
    • 产品：消融设备因其微创性和对肿瘤破坏的有效性而变得越来越重要
    • 最终使用者：介入性肿瘤学在门诊手术中心的应用日益广泛
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

6. 介入性肿瘤学市场（按产品）

  • 消融设备
    • 冷冻消融装置
    • 高强度聚焦超音波
  • 栓塞装置
    • 药物释放型珠
    • 微球
  • 辅助器具
    • 导管导引线套件

第七章介入肿瘤学市场（依癌症类型）

  • 大肠直肠癌
  • 肾癌
  • 肝癌
  • 肺癌

8. 介入性肿瘤学市场（依技术）

  • 放射线治疗
  • 影像导航放射治疗
  • 微波消融
  • 射频消融术

第九章介入肿瘤学市场（按最终用户）

  • 门诊手术中心
  • 癌症研究所
  • 医院

第 10 章：美洲介入肿瘤学市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第11章亚太介入肿瘤学市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

12. 欧洲、中东和非洲介入肿瘤学市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • Abbott Laboratories
  • Accuray Incorporated
  • Alpinion Medical Systems Co., Ltd.
  • AngioDynamics, Inc.
  • Atricure, Inc.
  • BALT Group
  • Bayer AG
  • Boston Scientific Corporation
  • Cook Group Incorporated
  • Eckert & Ziegler BEBIG AG
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • Hologic, Inc.
  • IceCure Medical Ltd.
  • Integer Holding Corporation
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips NV
  • Medtronic PLC
  • Merit Medical Systems
  • Profound Medical Corp.
  • Siemens Healthineers
  • Sirtex Medical Limited
  • Sonablate Corp
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-43127F7279CE

The Interventional Oncology Market was valued at USD 2.55 billion in 2024 and is projected to grow to USD 2.73 billion in 2025, with a CAGR of 7.39%, reaching USD 3.92 billion by 2030.

Comprehensive Introduction to Interventional Oncology

KEY MARKET STATISTICS
Base Year [2024] USD 2.55 billion
Estimated Year [2025] USD 2.73 billion
Forecast Year [2030] USD 3.92 billion
CAGR (%) 7.39%

Interventional oncology represents a dynamic and rapidly advancing field that combines cutting-edge technological innovations with a deep understanding of cancer biology. In today's complex healthcare environment, this specialty is emerging as a critical component in the management and treatment of malignant tumors. The introduction of minimally invasive techniques has not only redefined treatment paradigms but has also provided patients with safer, more effective alternatives to traditional surgical procedures. As an evolving sphere within oncology, interventional oncology leverages sophisticated imaging, tailored devices, and multi-modality approaches that enhance precision and accuracy, thereby improving patient outcomes.

This report offers an overarching view of the current state and future possibilities within the field. It encompasses an analysis of leading technological trends, key market drivers, and innovations in device development. The discussion extends to the clinical applications across various cancer types and the resultant transformations in therapeutic strategies. With a focus on actionable insights, this summary serves as both a strategic guide and a knowledge repository, offering valuable perspectives for practitioners, decision-makers, and industry leaders alike.

Emphasizing the importance of adaptability in a rapidly shifting healthcare landscape, the report sets the stage for a detailed examination of market segments, regional developments, and the competitive dynamics shaping this specialized area of oncology. In doing so, it highlights the integral role of research and collaboration in driving forward the next wave of breakthroughs in interventional oncology.

Transformative Shifts in the Landscape of Interventional Oncology

Recent years have witnessed transformative changes that are reshaping the realm of interventional oncology. Technological advancements have ushered in novel tools and approaches that are rewriting the clinical management of cancer. This evolution is largely driven by the need for enhanced precision, improved safety profiles, and more personalized treatment protocols.

Innovative imaging techniques, coupled with the evolution of miniaturized and highly specialized devices, have enabled clinicians to navigate complex tumor anatomies with remarkable accuracy. These developments significantly reduce treatment time and hospital stays, while also minimizing adverse effects associated with more invasive procedures. The integration of artificial intelligence and predictive analytics further supports clinical decision-making, ensuring that treatments are not only timely but also tailored to individual patient profiles.

Furthermore, the convergence of interdisciplinary expertise-spanning engineering, radiology, and oncology-forms the backbone of these transformative shifts. This holistic integration enhances the overall therapeutic process and streamlines patient care. As the landscape continues to evolve, the market is witnessing the emergence of novel therapeutic modalities and procedural innovations that challenge conventional paradigms. The momentum garnered from these changes emphasizes the need for continuous adaptation by stakeholders and paves the way for robust growth and innovation in the sector.

Key Segmentation Insights and Market Dynamics

Critical to understanding the market dynamics in interventional oncology is a comprehensive analysis of key segmentation parameters. The study of the product dimension reveals a spectrum that includes ablation, embolization, and supportive devices. Each of these categories is dissected further into specialized components such as cryoablation devices and high-intensity focused ultrasound within ablation devices; drug-eluting beads and microspheres within embolization devices; and guidewires and introduction kits classified under supportive devices. Such detailed categorization allows stakeholders to identify niche opportunities and address the specific needs of various clinical interventions.

Segmentation based on cancer type further refines this analysis by categorizing the market according to colorectal, kidney, liver, and lung cancers. These classifications underscore the diverse clinical applications and the variable incidence rates across different cancers, which in turn influence technology adoption and research prioritization.

Moreover, technological segmentation that encompasses brachytherapy, image-guided radiotherapy, microwave ablation, and radiofrequency ablation paints a picture of a field that is rapidly integrating innovative treatment modalities. This layered approach provides an in-depth view into the procedural intricacies and emerging competitive advantages.

Lastly, segmentation by end-user focuses on key clinical settings such as ambulatory surgical centers, cancer research institutes, and hospitals. Analyzing these segments offers actionable insights into the infrastructural demands and the evolving role of technology in enhancing patient management. Collectively, these segmentation insights provide a nuanced understanding of the market, highlighting growth trends and areas that require strategic investment.

Based on Product, market is studied across Ablation Devices, Embolization Devices, and Supportive Devices. The Ablation Devices is further studied across Cryoablation Devices and High-Intensity Focused Ultrasound. The Embolization Devices is further studied across Drug-Eluting Beads and Microspheres. The Supportive Devices is further studied across Guidewires and Introduction Kits.

Based on Cancer Type, market is studied across Colorectal Cancer, Kidney Cancer, Liver Cancer, and Lung Cancer.

Based on Technology, market is studied across Brachytherapy, Image-Guided Radiotherapy, Microwave Ablation, and Radiofrequency Ablation.

Based on End-User, market is studied across Ambulatory Surgical Centers, Cancer Research Institutes, and Hospitals.

Essential Regional Insights Shaping the Global Market

A robust appraisal of regional trends reveals significant variations and emerging opportunities on a global scale. In the Americas, advanced healthcare infrastructure combined with rapid adoption of technological innovations serves as a fertile ground for interventional oncology applications. The region's emphasis on integrating state-of-the-art diagnostic modalities and treatment techniques fuels ongoing research and development, thereby propelling market growth.

Turning to Europe, the Middle East, and Africa, a diverse spectrum of healthcare systems fosters an environment that is both challenging and rich with potential. The region is characterized by robust government initiatives and a heightened focus on precision medicine, which paves the way for the incorporation of advanced treatment devices and methodologies. Collaborative efforts between public and private sectors in this region are fostering technological diffusion and clinical excellence.

In Asia-Pacific, the combination of a large patient pool and expanding healthcare budgets has notably accelerated the market uptake of interventional oncology innovations. The region is witnessing a surge in infrastructural investments, which is coupled with a growing emphasis on early cancer detection and minimally invasive treatments. These regional insights illustrate how marketplace dynamics can vary dramatically, yet each region contributes uniquely to the overall advancement of interventional oncology practices across the globe.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

In-Depth Analysis of Leading Companies and Competitive Landscape

The competitive dynamics within the interventional oncology market are defined by the strategic initiatives and technological innovations of leading companies. Esteemed organizations such as Abbott Laboratories, Accuray Incorporated, Alpinion Medical Systems Co., Ltd., AngioDynamics, Inc., Atricure, Inc., BALT Group, Bayer AG, Boston Scientific Corporation, Cook Group Incorporated, Eckert & Ziegler BEBIG AG, Fujifilm Holdings Corporation, GE Healthcare, Hologic, Inc., IceCure Medical Ltd., Integer Holding Corporation, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Medtronic PLC, Merit Medical Systems, Profound Medical Corp., Siemens Healthineers, Sirtex Medical Limited, Sonablate Corp, Stryker Corporation, Teleflex Incorporated, and Terumo Corporation have played pivotal roles in shaping the market landscape.

These companies invest significantly in research and development, ensuring that their product offerings are at the forefront of innovation. Their portfolios not only encompass a range of sophisticated devices but also include innovative technical solutions that drive clinical efficiency and improved patient outcomes. Through strategic collaborations and mergers, the competitive arena continues to evolve, reflecting a trend towards greater consolidation in the industry.

Analyzing these companies offers several insights, including their market penetration strategies, focus on emerging technologies, and dedication to clinical validation. In addition, their extensive global networks allow them to effectively respond to regional needs and regulatory frameworks. As a result, their collective efforts are not only pushing technological boundaries but are also setting new benchmarks in patient care and clinical excellence.

The report delves into recent significant developments in the Interventional Oncology Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accuray Incorporated, Alpinion Medical Systems Co., Ltd., AngioDynamics, Inc., Atricure, Inc., BALT Group, Bayer AG, Boston Scientific Corporation, Cook Group Incorporated, Eckert & Ziegler BEBIG AG, Fujifilm Holdings Corporation, GE Healthcare, Hologic, Inc., IceCure Medical Ltd., Integer Holding Corporation, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Medtronic PLC, Merit Medical Systems, Profound Medical Corp., Siemens Healthineers, Sirtex Medical Limited, Sonablate Corp, Stryker Corporation, Teleflex Incorporated, and Terumo Corporation. Actionable Recommendations for Industry Leaders

Industry leaders are encouraged to adopt a multi-faceted strategy that addresses both the immediate and long-term challenges faced by the interventional oncology sector. A significant recommendation is to continue investing in research and digital transformation. Embracing innovations such as artificial intelligence, machine learning, and predictive analytics will enable a more precise alignment of treatment strategies with patient-specific needs.

Moreover, firms should focus on strengthening cross-disciplinary collaborations that integrate clinical expertise with technological advancements. By leveraging synergies between engineering, radiology, and oncology, practices can enhance procedural accuracy and broaden the scope of minimally invasive treatments. Strategic partnerships with research institutions and healthcare providers can also generate a robust pipeline of innovative solutions.

Operational excellence is another critical area; streamlining supply chains, optimizing production cycles, and ensuring regulatory compliance across diverse markets will be crucial. Leaders should also pay keen attention to regional market demands and patient demographics to tailor solutions that are both cost-effective and clinically impactful. Investing in workforce development and continuous training will further enable organizations to sustain competitive advantages.

Ultimately, these actionable steps form the foundation of a comprehensive strategy that not only optimizes current operations but also secures long-term market leadership in an increasingly competitive landscape.

Concise Conclusion and Strategic Insights

In conclusion, interventional oncology is advancing at a remarkable pace, driven by technological innovations, strategic market segmentation, and regional investments that collectively point to sustained industry growth. This evolving landscape presents significant opportunities for enhanced patient care, as well as challenges that require dynamic strategic responses.

Focused analysis across diverse segments, regions, and competitive benchmarks highlights the necessity for integrated approaches that combine clinical expertise with advanced technology. The insights gleaned from this comprehensive overview elucidate the key trends and strategic imperatives that will continue to shape the future of interventional oncology.

Stakeholders are thus well-positioned to capitalize on these emerging opportunities by aligning their strategies with the evolving market dynamics, thereby ensuring long-term success and resilience in a rapidly transforming field.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of cancer globally
      • 5.1.1.2. Rising awareness and acceptance of interventional oncology as a treatment option among patients and providers
      • 5.1.1.3. Increasing healthcare expenditure and investments in interventional oncology worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with interventional oncology procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of artificial intelligence in optimizing workflow and diagnosis in interventional oncology
      • 5.1.3.2. Advancements in cryoablation technology for minimally invasive cancer treatments
    • 5.1.4. Challenges
      • 5.1.4.1. Addressing concerns about the clinical efficacy and safety of emerging interventional oncology
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Rising significance of ablation devices owing to their minimally invasive nature and effectiveness in tumour destruction
    • 5.2.2. End-User: Expanding adoption of interventional oncology among ambulatory surgical centers
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Interventional Oncology Market, by Product

  • 6.1. Introduction
  • 6.2. Ablation Devices
    • 6.2.1. Cryoablation Devices
    • 6.2.2. High-Intensity Focused Ultrasound
  • 6.3. Embolization Devices
    • 6.3.1. Drug-Eluting Beads
    • 6.3.2. Microspheres
  • 6.4. Supportive Devices
    • 6.4.1. Guidewires
    • 6.4.2. Introduction Kits

7. Interventional Oncology Market, by Cancer Type

  • 7.1. Introduction
  • 7.2. Colorectal Cancer
  • 7.3. Kidney Cancer
  • 7.4. Liver Cancer
  • 7.5. Lung Cancer

8. Interventional Oncology Market, by Technology

  • 8.1. Introduction
  • 8.2. Brachytherapy
  • 8.3. Image-Guided Radiotherapy
  • 8.4. Microwave Ablation
  • 8.5. Radiofrequency Ablation

9. Interventional Oncology Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Cancer Research Institutes
  • 9.4. Hospitals

10. Americas Interventional Oncology Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Interventional Oncology Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Interventional Oncology Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. FPNV Positioning Matrix, 2024
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Delcath Systems secures USD 16.3 million through warrant exercises to advance liver cancer treatment strategies
    • 13.3.2. Boston Scientific expands interventional oncology offerings with acquisition of Intera Oncology Inc to enhance liver cancer treatments
    • 13.3.3. Varian secures FDA clearance for IntelliBlate microwave ablation ecosystem
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Accuray Incorporated
  • 3. Alpinion Medical Systems Co., Ltd.
  • 4. AngioDynamics, Inc.
  • 5. Atricure, Inc.
  • 6. BALT Group
  • 7. Bayer AG
  • 8. Boston Scientific Corporation
  • 9. Cook Group Incorporated
  • 10. Eckert & Ziegler BEBIG AG
  • 11. Fujifilm Holdings Corporation
  • 12. GE Healthcare
  • 13. Hologic, Inc.
  • 14. IceCure Medical Ltd.
  • 15. Integer Holding Corporation
  • 16. Johnson & Johnson Services, Inc.
  • 17. Koninklijke Philips N.V.
  • 18. Medtronic PLC
  • 19. Merit Medical Systems
  • 20. Profound Medical Corp.
  • 21. Siemens Healthineers
  • 22. Sirtex Medical Limited
  • 23. Sonablate Corp
  • 24. Stryker Corporation
  • 25. Teleflex Incorporated
  • 26. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. INTERVENTIONAL ONCOLOGY MARKET MULTI-CURRENCY
  • FIGURE 2. INTERVENTIONAL ONCOLOGY MARKET MULTI-LANGUAGE
  • FIGURE 3. INTERVENTIONAL ONCOLOGY MARKET RESEARCH PROCESS
  • FIGURE 4. INTERVENTIONAL ONCOLOGY MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 17. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 19. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. INTERVENTIONAL ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 25. INTERVENTIONAL ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. INTERVENTIONAL ONCOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INTERVENTIONAL ONCOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CRYOABLATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY DRUG-ELUTING BEADS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY INTRODUCTION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY KIDNEY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY LIVER CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY IMAGE-GUIDED RADIOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY MICROWAVE ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 283. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 290. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 297. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 304. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 311. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 325. INTERVENTIONAL ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 326. INTERVENTIONAL ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2024